Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 118
- Uncategorized
Bröckelnde SPD-Unterstützung bedroht Zukunft des deutschen CanG-Gesetzes
Das deutsche Cannabisgesetz (CanG) wird zunehmend unsicherer, da die Unterstützung innerhalb der größten Partei der Koalition bröckelt und Kritik an dem Gesetzentwurf von verschiedenen Seiten aufkommt.
- Adult-Use
Crumbling SPD Support Threatens Future of Germany’s CanG Bill
Germany’s Cannabis Act (CanG) is entering increasingly uncertain territory as support within the coalition’s largest party crumbles, and criticism of the bill begins to surface on multiple fronts.
- Press releases
Innovative Business Leader Stef Kulik Joins CIC Board
Highly experienced and innovative business leader Stef Kulik has joined the Board of the Cannabis Industry Council (CIC) as a Non Executive Director.
- Companies
Oregon’s Cannabis Business Owners Call For New Measures to Tackle Oversaturation
Cannabis business owners in Oregon have called on lawmakers to permanently limit the number of new licenses granted in an effort to tackle market saturation.
- Uncategorized
Missouri Court Officials Request $3.7m to Continue Cannabis Expungements
Missouri Court officials have requested a further $3.7m to fund its ongoing commitment to cannabis expungements over the coming year.
- Markets & Stocks
Akanda Avoids NASDAQ Delisting, Kanabo to Open Walk-in Clinic, & Hellenic Makes Funding Progress
Akanda [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”AKAN” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] Akanda has seen its stock rise by around 7% this week as it rode the wave of positive sentiment sending US-listed cannabis stocks skyrocketing.
- Uncategorized
US Cannabis Stock Prices up 25% Since Publication of Rescheduling Recommendation
US cannabis stock prices have rallied once again this week following the publication of the fully unredacted 252-page cannabis rescheduling recommendation.
- Opinion
US Cannabis Rescheduling Primed to Set Off a Global Cannabis Explosion
Written by Michael Sassano, CEO, Somai Pharmaceuticals On January 12, the United States Department of Health and Human Services (HHS) released a letter and supporting 252-page document that will make it extremely difficult for the Drug Enforcement Agency (DEA) to ignore its findings on the benefits of cannabis and all but ensuring that the U.S.
- Press releases
Medical Cannabis Significantly Improves Symptoms of Chronic Depression, New Study Suggests
LVR University Hospital Essen, in collaboration with Algea Care, Europe’s leading telehealth platform for cannabis, has announced the results of a groundbreaking study on the efficacy of medical cannabis in treating chronic depression: patients showed significant improvement, with the reported severity rate of their depression reduced significantly, with no severe side effects and a low…
- Uncategorized
Teva Pharmaceuticals Fails to Disqualify Jazz Pharmaceuticals’ Epidyolex Patent In Court
Jazz Pharmaceuticals has rebuffed attempts by rival Teva Pharmaceuticals to legally disqualify its patent for Epidyolex, a cannabis-based drug worth hundreds of millions of dollars a year.
- Uncategorized
Colorado’s Cannabis Market Hit Lowest Sales Since 2015 in November 2023
Colorado’s cannabis market continued its substantial decline in the closing months of 2023, seeing cannabis sales fall to their lowest level since February 2015 in November.
- Press releases
Kanabo Announces Partnership With City Dock Pharmacy to Launch a Walk-in Pain Clinic
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce it has signed a partnership with City Dock Pharmacy in London, to launch a walk-in pain clinic offering specialised medicines, including medicinal cannabis, which is the first of its kind.
